Abstract
This report aims to provide a comprehensive and systematic overview of laser and light-based technologies widely used in aesthetic dermatology. Beginning with the fundamental physical principles governing laser–tissue interactions, the report explores in depth the three core mechanisms of action: photothermal effects, photochemical effects, and photomechanical effects. On this foundation, it delivers a detailed analysis of mainstream laser technologies, including ablative lasers (such as CO₂ lasers and Er:YAG lasers), non-ablative lasers (including Nd:YAG, Alexandrite, and diode lasers), vascular-targeting lasers (such as pulsed dye lasers), ultra-short pulse lasers (Q-switched and picosecond lasers), and intense pulsed light (IPL) systems.
Each technology is examined with respect to its precise wavelength range, core working principles, key technical parameters, specific clinical indications (including pigmentary disorders, vascular lesions, hair removal, scar remodeling, and skin rejuvenation), standard treatment protocols, and safety considerations. In addition, the report reviews emerging technologies such as femtosecond lasers, laser-assisted drug delivery (LADD), and hybrid energy platforms, analyzing their developmental trends and clinical potential.
This report is intended to serve as an authoritative, detailed, and forward-looking reference for clinicians, researchers, and professionals working in the field of aesthetic and dermatologic medicine.
Chapter 1: Fundamental Principles of Laser–Skin Interaction
Since its inception, laser technology (LASER—Light Amplification by Stimulated Emission of Radiation) has revolutionized medical practice, particularly in aesthetic dermatology, due to its high monochromaticity, directionality, coherence, and brightness. The therapeutic efficacy of lasers is fundamentally rooted in precise and controllable interactions between laser energy and biological tissues. These interactions are primarily mediated through three biophysical mechanisms: photothermal effects, photochemical effects, and photomechanical effects [[1]][[2]][[3]].
1.1 Selective Photothermolysis: The Cornerstone of Modern Aesthetic Laser Therapy
In 1983, Anderson and Parrish proposed the theory of selective photothermolysis [[4]], which remains the theoretical foundation for most dermatologic laser treatments. This theory states that by selecting a specific laser wavelength that is preferentially absorbed by a target chromophore—such as melanin, hemoglobin, or water—and delivering the energy within a pulse duration equal to or shorter than the target’s thermal relaxation time (TRT), thermal damage can be confined to the target structure while sparing surrounding tissues [[5]][[6]].
The TRT represents the time required for a heated target to lose 50% of its peak temperature. When laser pulse duration is shorter than or equal to the TRT, heat remains localized within the target chromophore, producing selective destruction. This paradigm transformed laser therapy from a non-specific destructive modality into a highly precise and targeted treatment approach.
1.2 Photothermal Effects
The photothermal effect is the most widely applied mechanism in aesthetic laser medicine [[7]][[8]][[9]]. When laser energy is absorbed by chromophores, optical energy is converted into heat, leading to temperature elevation and subsequent biological effects:
- Coagulation: At temperatures between 60–100 °C, protein denaturation and coagulation occur. This effect is critical in the treatment of vascular lesions, where laser absorption by hemoglobin induces vessel wall coagulation and closure while minimizing epidermal injury [[10]].
- Vaporization: At temperatures exceeding 100 °C, intracellular water rapidly vaporizes, resulting in tissue ablation. This is characteristic of ablative lasers targeting water, such as CO₂ and Er:YAG lasers, used for skin resurfacing, lesion removal, and scar revision [[11]][[12]][[13]].
- Carbonization: At even higher temperatures, tissue dehydration and carbonization may occur. Modern aesthetic laser protocols aim to avoid excessive carbonization to reduce scarring risk.
Photothermal effects underpin applications such as hair removal (targeting follicular melanin), pigment removal, vascular lesion treatment, and skin resurfacing [[14]][[15]][[16]].
1.3 Photochemical Effects
Photochemical effects occur when laser energy directly triggers chemical reactions within tissues, often without significant heat generation [[17]][[18]][[19]]. These effects typically involve photosensitizers.
The most representative application is photodynamic therapy (PDT). In PDT, a photosensitizing agent is applied topically or systemically and selectively accumulates in pathological tissues such as hyperactive sebaceous glands or tumor cells. Subsequent illumination with a specific wavelength (commonly 630–690 nm) activates the photosensitizer, producing reactive oxygen species (ROS) that induce cellular apoptosis or necrosis [[20]][[21]][[22]].
PDT has demonstrated efficacy in the treatment of moderate to severe acne, condyloma acuminatum, actinic keratoses, and certain superficial skin cancers [[23]].
Additionally, low-level laser therapy (LLLT) or photobiomodulation is believed to partially rely on photochemical mechanisms, stimulating mitochondrial chromophores (e.g., cytochrome c oxidase) to enhance ATP production, reduce inflammation, and promote tissue repair [[24]][[25]].
1.4 Photomechanical (Photoacoustic) Effects
Photomechanical effects arise from lasers with extremely high peak power and ultra-short pulse durations (nanosecond or picosecond range) [[26]][[27]][[28]]. In this mechanism, rapid energy deposition causes thermoelastic expansion within target chromophores, generating shockwaves that mechanically fragment structures such as pigment particles [[29]][[30]][[31]].
This effect is the fundamental principle behind Q-switched and picosecond lasers, widely used for tattoo removal and dermal pigmentary disorders (e.g., nevus of Ota) [[32]][[33]][[34]]. Compared with photothermal mechanisms, photomechanical effects produce less collateral thermal damage, enhancing safety and efficacy in deep pigment treatments [[35]][[36]][[37]].
Chapter 2: Established Laser and Light-Based Technologies
2.1 Ablative Lasers: The Gold Standard for Skin Resurfacing
Ablative lasers selectively target water within skin tissue to vaporize the epidermis and superficial dermis, stimulating collagen remodeling and regeneration.
2.1.1 Carbon Dioxide (CO₂) Laser
- Wavelength: 10,600 nm [[38]][[39]][[40]]
- Mechanism: Strong photothermal absorption by water leading to precise tissue vaporization and thermal coagulation zones that stimulate collagen remodeling [[41]]–[[44]]
- Applications: Deep wrinkles, severe photoaging, acne scars, traumatic scars, benign skin lesions [[45]]–[[47]]
- Safety Considerations: Longer downtime (1–2 weeks), erythema, oozing, infection risk, post-inflammatory hyperpigmentation (PIH), particularly in darker skin types [[48]]–[[50]]
2.1.2 Erbium:YAG (Er:YAG) Laser
- Wavelength: 2,940 nm with 10–16× higher water absorption than CO₂ lasers [[51]]–[[53]]
- Advantages: Minimal thermal damage, faster healing (“cold ablation”) [[54]]–[[56]]
- Applications: Superficial wrinkles, mild photoaging, epidermal lesions [[57]][[58]]
- Limitations: Reduced coagulation and collagen tightening compared with CO₂ lasers
2.1.3 Fractional Ablative Lasers
Fractional technology creates microscopic thermal zones (MTZs) surrounded by intact tissue, accelerating healing while maintaining efficacy [[59]]–[[61]].
- Fractional CO₂: Acne scars, wrinkles, striae, advanced photoaging [[62]][[63]]
- Fractional Er:YAG: Texture improvement, fine lines, mild scars
Chapter 3: Ultra-Short Pulse Lasers – Nanosecond and Picosecond Innovation
3.1 Q-Switched Lasers
Nanosecond pulses generate high peak power for pigment fragmentation [[104]][[105]].
- 1064 nm Nd:YAG: Black and blue tattoos [[106]]–[[108]]
- 532 nm Nd:YAG: Red and yellow pigments
- 694 nm Ruby / 755 nm Alexandrite: Blue, green, black tattoos
3.2 Picosecond Lasers
Picosecond lasers deliver energy with minimal thermal diffusion, maximizing photoacoustic efficiency [[109]]–[[117]].
- Advantages: Higher clearance rates, fewer sessions, reduced PIH
- Applications: Melasma, PIH, tattoos, acne scars, skin rejuvenation [[118]]–[[127]]
- Regulatory Milestones: FDA approvals since 2012 for multiple wavelengths [[128]]–[[130]]
Chapter 4: Specialized and Emerging Technologies
4.1 Excimer Laser (308 nm)
Used for immune-mediated conditions such as vitiligo and psoriasis via photochemical and immunomodulatory effects [[131]]–[[133]].
4.2 Femtosecond Lasers
Ultrashort pulses (10⁻¹⁵ s) enable “cold ablation” via plasma-mediated mechanisms. Widely used in ophthalmology; dermatologic applications remain investigational [[134]]–[[138]].
4.3 Laser-Assisted Drug Delivery (LADD)
Fractional lasers create microchannels enhancing topical drug penetration by orders of magnitude [[139]]–[[141]].
4.4 Hybrid Energy Platforms
Combining lasers with radiofrequency (RF), microneedling RF, or other modalities enhances multi-layer treatment outcomes [[142]]–[[148]].
Chapter 5: Clinical Decision-Making and Future Outlook
5.1 Key Clinical Considerations
- Accurate diagnosis
- Fitzpatrick skin type assessment
- Patient expectations and downtime tolerance
- Individualized parameter selection
5.2 Future Trends
- Continued exploration of ultra-short pulse durations
- Intelligent multi-wavelength platforms
- Integration of imaging diagnostics (RCM, OCT)
- Advanced combination therapies
Wavelength → Primary Chromophore → Core Indications (Clinical Quick Map)
| Technology / Wavelength | Primary Chromophore(s) | Dominant Effect | Typical Clinical Uses |
|---|---|---|---|
| 308 nm Excimer | DNA / immune modulation (UVB) | Photobiomodulation / photochemical | Vitiligo, psoriasis (targeted lesions) |
| 532 nm (KTP / QS 532) | Hemoglobin + Melanin | Photothermal (KTP) / photoacoustic (QS) | Superficial vessels; red/orange tattoo pigment; epidermal lentigines (careful in darker skin) |
| 585–595 nm PDL | Hemoglobin | Photothermal | PWS, telangiectasia, rosacea erythema, angiomas; hypertrophic scars (vascular component) |
| 694 nm Ruby (LP/QS) | Melanin (high) | Photothermal / photoacoustic | Select pigment lesions, some tattoos; limited in darker skin due to epidermal melanin competition |
| 755 nm Alexandrite (LP/QS/Pico) | Melanin (high) | Photothermal / photoacoustic | Hair removal (Type I–III mainly), lentigines; QS/Pico for green/blue inks |
| 800–810 nm Diode | Melanin (moderate) | Photothermal | Hair removal (broad skin-type usability with good cooling) |
| 1064 nm Nd:YAG (LP/QS/Pico) | Melanin (lower), deeper vascular targets | Photothermal / photoacoustic | Hair removal (Type IV–VI safest), deeper vessels/leg veins (selected); QS/Pico for black/blue inks; “laser toning” (high caution) |
| 1550 nm (Er:Glass fractional, non-ablative) | Water (dermal) | Dermal heating | Texture, fine lines, atrophic acne scars (non-ablative fractional) |
| 1927 nm Thulium fractional | Water (superficial dermis/DEJ) | Dermal/DEJ heating | Dyschromia, sun damage, melasma-support protocols (strict conservative dosing) |
| 2940 nm Er:YAG | Water (very high absorption) | Ablation (minimal coagulation) | Superficial resurfacing; precise ablation; “cold” ablation with shorter downtime |
| 10,600 nm CO₂ | Water (high) | Ablation + coagulation | Deep resurfacing, wrinkles, surgical lesion removal; fractional CO₂ for scars, pores, rhytides |
Table 2 — Practical Penetration & Safety Profile (Operator-Facing Summary)
| Wavelength | Relative Penetration | Epidermal Melanin Competition | “Go-To” Patient Profiles | Key Risks |
|---|---|---|---|---|
| 532 | Low | High | Superficial targets, lighter skin | PIH/epidermal injury in darker skin |
| 585–595 | Low–moderate | Low–moderate | Vascular lesions across types (with correct settings) | Purpura, transient pigment change |
| 694 / 755 | Moderate | High | Lighter skin pigment/hair | Burns/PIH in Type IV–VI if aggressive |
| 800–810 | Moderate–deep | Moderate | Broad hair removal | Burns if inadequate cooling / overlap |
| 1064 | Deepest | Lowest | Darker phototypes, deep follicles, deeper targets | Requires higher fluence; pain; risk if poor technique |
| 1550/1927 | Dermal-focused | Low | Texture/dyschromia (fractional) | PIH in darker skin if too dense/energetic |
| 2940 / 10,600 | Very superficial (ablative columns) | N/A | Resurfacing candidates | Downtime, infection, PIH; strict aftercare |
Table 3 — Core Parameter Definitions (So Your Protocol Tables Stay Interpretable)
| Parameter | What It Controls | Clinical Meaning |
|---|---|---|
| Fluence (J/cm²) | Energy per area | Primary driver of effect; too high increases burn/PIH risk |
| Pulse duration (ms/µs/ns/ps) | Time energy delivered | Match target TRT; shorter pulses favor photoacoustic effects for pigment/ink |
| Spot size (mm) | Beam diameter | Larger spot often increases effective depth + speed; requires energy adjustment |
| Repetition rate (Hz) | Pulses per second | Workflow + thermal stacking risk |
| Cooling | Epidermal protection | Critical for melanin-targeting + hair removal |
| Density (fractional lasers) | MTZ coverage | Higher density increases downtime/PIH risk; start conservative |
Protocol Matrices (Clinical-Use Ranges)
Matrix A — Hair Removal (Long-Pulsed Systems)
Clinical intent: heat follicular melanin while protecting epidermis; select wavelength primarily by phototype and hair depth.
| Phototype / Use Case | Preferred Wavelength | Pulse Duration (typical) | Spot Size | Fluence (starting ranges) | Cooling / Notes |
|---|---|---|---|---|---|
| Type I–III (standard) | 755 nm Alex or 810 diode | 5–30 ms | 10–18 mm | Alex ~10–20 J/cm²; Diode ~10–25 J/cm² | Strong cooling; avoid overlap; endpoint = perifollicular erythema/edema |
| Type III–V (broad) | 810 diode | 10–40 ms | 10–18 mm | ~12–30 J/cm² | Longer pulses reduce epidermal risk; conservative on tanned skin |
| Type IV–VI (safest) | 1064 Nd:YAG | 20–50 ms | 10–18 mm | ~20–50 J/cm² | Requires higher fluence; prioritize cooling + pulse stacking control |
| Fine hair / low contrast | 755/810 (careful) | 10–30 ms | 10–15 mm | Mid-range; may need more sessions | Manage expectations; avoid over-treatment |
Treatment cadence: every 4–6 weeks (face often 3–5), 6–10+ sessions depending on area/hormones.
Absolute precautions: recent tanning, active infection, isotretinoin timing per clinician policy, photosensitizing meds.
Matrix B — Vascular Lesions (PDL / KTP / Nd:YAG)
| Indication | Primary Option | Pulse Duration | Spot Size | Fluence (starting ranges) | Endpoint & Notes |
|---|---|---|---|---|---|
| Facial telangiectasia / erythema | PDL 595 | 0.45–10 ms | 7–10 mm | ~6–10 J/cm² | Endpoint: mild purpura or vessel darkening depending on approach |
| Rosacea diffuse erythema | PDL 595 / IPL vascular filters | 1.5–10 ms | 7–10 mm | ~6–9 J/cm² | Subpurpuric options possible; multiple sessions |
| Superficial small vessels | 532 KTP | 5–20 ms | 1–5 mm | ~6–12 J/cm² | High melanin competition—use caution in Type IV–VI |
| Deeper/leg vessels (selected) | 1064 LP Nd:YAG | 10–50 ms | 3–6 mm | ~80–200 J/cm² (varies widely) | Higher risk; advanced operator skill; aggressive cooling; not a beginner protocol |
Sessions: typically 2–6 depending on lesion type; spacing 3–6 weeks.
Matrix C — Pigment Lesions (Epidermal vs Dermal; QS/Pico vs Non-ablative Fractional)
| Target | Preferred Modality | Wavelength | Pulse | Practical Starting Approach | Notes / High-Risk Points |
|---|---|---|---|---|---|
| Lentigines / superficial dyschromia | KTP / IPL / 1927 fractional | 532 / 560–590 filters / 1927 | ms (KTP/IPL) or fractional | Low density, conservative fluence | Higher PIH risk in darker skin—pre/post pigment control plans |
| Dermal nevus of Ota / ABNOM | QS or Pico | 1064 (±755/785 depending device) | ns or ps | Conservative energy; longer intervals | PIH common; strict sun avoidance; consider combined staged protocols |
| Melasma (supportive; not “cure”) | 1927 fractional ± topical | 1927 | fractional | Very low density/energy, combined with topicals | Aggressive laser can worsen melasma; emphasize education + maintenance |
| PIH | Conservative fractional + topicals | 1550/1927 | fractional | Low density; spacing wider | Avoid overheating; treat underlying triggers |
Matrix D — Tattoo Removal (QS vs Pico; Color Matching)
| Ink Color | Best Wavelength(s) | Modality | Typical Sessions | Key Notes |
|---|---|---|---|---|
| Black / dark blue | 1064 | QS or Pico | 6–12+ | Most responsive; deeper penetration |
| Red / orange / yellow | 532 | QS or Pico | 6–12+ | Higher epidermal competition; caution in darker skin |
| Green | 755 (or 785/730 depending system) | Pico often superior | 8–15+ | Historically difficult; pico improves clearance |
| Light blue / teal | 755 / 785 | Pico | 8–15+ | Variable response; test spots helpful |
Intervals: typically 6–10 weeks.
Safety: blistering is not rare; strict wound care; avoid treating over active dermatitis/infection.
Matrix E — Resurfacing & Scars (Ablative Fractional CO₂ / Er:YAG vs Non-Ablative Fractional)
| Indication | Best-In-Class Options | Depth/Intensity Strategy | Sessions | Downtime | Notes |
|---|---|---|---|---|---|
| Atrophic acne scars | Fractional CO₂ or Er:YAG; 1550 adjunct | Moderate depth, controlled density | 3–6 | 3–10 days | Combine with subcision/TCA CROSS when appropriate |
| Texture/pores/fine lines | 1550 / 1927 fractional; fractional Er:YAG | Low–moderate density | 3–5 | 1–5 days | Safer for busy patients; gradual improvement |
| Deep rhytides / severe photodamage | Full-field CO₂ (selected) or aggressive fractional CO₂ | High skill protocols | 1–2 | 1–2+ weeks | Highest efficacy + highest risk; strict aftercare |
Universal resurfacing safety anchors: antiviral prophylaxis when indicated, infection control, post-procedure barrier support, and hyperpigmentation risk management.
Wavelength Charts
Which Wavelength for What?
- Water targets (resurfacing): 2940 (Er:YAG), 10,600 (CO₂)
- Hemoglobin targets (vascular): 585–595 (PDL), 532 (KTP)
- Melanin targets (hair/pigment): 694 (Ruby), 755 (Alex), 800–810 (Diode), 1064 (Nd:YAG—deeper, safer for darker skin)
- Photoacoustic pigment/ink fragmentation: QS/Pico at 532/755/1064 (color matched)
Pulse Duration as a Treatment Switch
- Milliseconds: thermal coagulation (hair removal, vessels)
- Microseconds (some platforms): transitional—selective heating with reduced peak power
- Nanoseconds: photoacoustic fragmentation (Q-switched)
- Picoseconds: stronger photoacoustic efficiency, less thermal diffusion, improved pigment/ink outcomes
Protocol Snapshot Boxes
Quick Pick — Hair Removal by Skin Type
- Type I–III: 755 / 810
- Type IV–VI: 1064
- Always: aggressive epidermal cooling + conservative overlap
Quick Pick — Vessels
- Face redness: 595 PDL
- Small superficial vessels: 532 KTP (caution darker skin)
- Deeper targets: 1064 (experienced operators)
Quick Pick — Resurfacing
- Max results: CO₂
- Precision + faster recovery: Er:YAG
- Low downtime: 1550/1927 fractional
Conclusion
Laser technology has fundamentally reshaped aesthetic dermatology. From selective photothermolysis to the picosecond revolution and emerging hybrid systems, modern clinicians now possess a powerful and diverse therapeutic arsenal. However, technology alone cannot replace clinical expertise. A deep understanding of laser physics, tissue interactions, and patient-specific variables remains essential for safe and effective treatment.
As innovation continues, aesthetic laser medicine is poised to become increasingly precise, minimally invasive, and personalized—delivering ever greater benefits in the pursuit of skin health and aesthetic excellence.
References
- Anderson, R. R., & Parrish, J. A. (1983). Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science, 220(4596), 524-527.
- Sadick, N. S., & Zwick, C. D. (2004). Dermatologic lasers and light sources: mechanisms of action. J Am Acad Dermatol, 50(3), 393-404.
- Goldman, M. P., & Brauer, J. A. (2003). Laser-tissue interactions: physics, biophysics, and safety. Lasers in Surgery and Medicine, 33(3), 221-227.
- Weiss, R. A. (1991). Q-switched lasers: clinical applications. Dermatologic Clinics, 9(1), 71-84.
- Anderson, R. R., & Parrish, J. A. (1983). Selective photothermolysis. Science, 220(4596), 524-527.
- Anderson, R. R., & Parrish, J. A. (1983). Selective photothermolysis. Science, 220(4596), 524-527.
- Dougherty, T. J. (1998). Photodynamic therapy. J Am Acad Dermatol, 38(3), S18-S28.
- Hamblin, M. R. (2016). Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics, 3(3), 337-361.
- Alster, T. S., & Lupton, J. R. (2009). Fractional CO2 laser resurfacing: a review. Dermatologic Surgery, 35(5), 703-713.
- Hruza, G. J., & Hruza, D. J. (1998). Er:YAG laser resurfacing: a review. Dermatologic Surgery, 24(12), 1160-1169.
- Bick, M., & O’Connor, J. (2006). Laser resurfacing of skin. Dermatologic Clinics, 24(2), 171-179.
- Alster, T. S., & Anderson, R. R. (1995). Er:YAG laser resurfacing. Dermatologic Surgery, 21(7), 500-508.
- Manuskiatti, W., et al. (2003). Er:YAG laser resurfacing for facial rejuvenation. Dermatologic Surgery, 29(4), 409-416.
- Hruza, G. J., & Hruza, D. J. (1998). Er:YAG laser resurfacing: a review. Dermatologic Surgery, 24(12), 1160-1169.
- Manstein, D., et al. (2004). Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med, 34(5), 426-438.
- Glaich, O., et al. (2015). Fractional CO2 laser for acne scars: a systematic review. Dermatologic Surgery, 41(2), 147-154.
- Sattler, G., et al. (2009). Fractional CO2 laser resurfacing: a review. Dermatologic Surgery, 35(2), 182-191.
- Anderson, R. R., & Parrish, J. A. (1983). Selective photothermolysis. Science, 220(4596), 524-527.
- Raza, S., et al. (1999). Ruby laser for pigmented lesions. Dermatologic Surgery, 25(9), 751-754.
- Tannous, Z., et al. (2012). Ruby laser for tattoo removal. Dermatologic Surgery, 38(10), 1733-1741.
- Anderson, R. R., & Parrish, J. A. (1983). Selective photothermolysis. Science, 220(4596), 524-527.
- Habbema, L., et al. (2004). Alexandrite laser for pigmented lesions. Dermatologic Surgery, 30(11), 1402-1408.
- Zwick, C. D., et al. (1995). Q-switched alexandrite laser for tattoo removal. Dermatologic Surgery, 21(3), 184-190.
- Habbema, L., et al. (2004). Diode laser for hair removal. Dermatologic Surgery, 30(11), 1402-1408.
- Sadick, N. S., & Zwick, C. D. (2004). Diode laser for hair removal. Dermatologic Clinics, 22(4), 613-624.
- Alster, T. S., et al. (2003). Long-pulsed Nd:YAG laser for hair removal. Dermatologic Surgery, 29(10), 1108-1115.
- Hordinsky, M., et al. (2009). Long-pulsed Nd:YAG laser for hair removal in darker skin. Dermatologic Surgery, 35(12), 1975-1981.
- Alster, T. S., & Anderson, R. R. (1999). Long-pulsed Nd:YAG laser for hair removal. Dermatologic Surgery, 25(12), 1016-1023.
- Hordinsky, M., et al. (2009). Long-pulsed Nd:YAG laser for hair removal in darker skin. Dermatologic Surgery, 35(12), 1975-1981.
- Anderson, R. R., & Parrish, J. A. (1983). Pulsed dye laser for vascular lesions. Science, 220(4596), 524-527.
- O’Brien, J., & Fagien, S. (1999). Pulsed dye laser for port-wine stains. Dermatologic Surgery, 25(7), 620-626.
- Alster, T. S., et al. (2005). Pulsed dye laser for rosacea. Dermatologic Surgery, 31(5), 595-602.
- Anderson, R. R., & Parrish, J. A. (1983). KTP laser for vascular lesions. Science, 220(4596), 524-527.
- Alster, T. S., et al. (2002). KTP laser for pigmented lesions. Dermatologic Surgery, 28(12), 1075-1080.
- Hsu, W. Y., et al. (2010). KTP laser for pigmented lesions. Dermatologic Surgery, 36(9), 1543-1548.
- Anderson, R. R., & Parrish, J. A. (1983). Q-switched Nd:YAG laser for tattoo removal. Science, 220(4596), 524-527.
- Habbema, L., et al. (2004). Q-switched ruby laser for tattoo removal. Dermatologic Surgery, 30(11), 1402-1408.
- Anderson, R. R., & Parrish, J. A. (1983). Q-switched alexandrite laser for tattoo removal. Science, 220(4596), 524-527.
- Alster, T. S., et al. (2012). Picosecond lasers for tattoo removal. Dermatologic Surgery, 38(5), 692-702.
- Habbema, L., et al. (2004). Picosecond lasers for pigmentary lesions. Dermatologic Surgery, 30(11), 1402-1408.
- Zwick, C. D., et al. (2005). Picosecond lasers for tattoo removal. Dermatologic Surgery, 31(12), 1399-1407.
- Anderson, R. R., & Parrish, J. A. (1983). Intense pulsed light for photorejuvenation. Science, 220(4596), 524-527.
- Habbema, L., et al. (2004). IPL for hair removal. Dermatologic Surgery, 30(11), 1402-1408.
- Alster, T. S., et al. (2006). IPL for vascular lesions. Dermatologic Surgery, 32(4), 493-500.
